Records containing: Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-12-02A Double Blind, Randomized, Placebo Controlled, Parallel Group Phase IIa Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients With Mild to Moderate Essential Hypertension
-
CLINICAL_TRIALS study record update · 2009-12-01Clinical Protocol For A Double-Blind, Randomized, Active- Controlled Comparison Study Of The Antihypertensive Effect Of Eplerenone Versus Losartan In Patients With Mild To Moderate Hypertension
-
CLINICAL_TRIALS study record update · 2009-11-23Simvastatin in the Treatment of Isolated Arterial hyPertension and Prevention of cARdiovascular Events
-
CLINICAL_TRIALS study record update · 2009-11-20A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Exploratory, 28-Day Study to Examine the Effects of AR9281 on Blood Pressure and Glucose Tolerance in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
-
CLINICAL_TRIALS study record update · 2009-11-18A Comparison of Telmisartan Effectiveness in Hypertensive Patients With and Without Albuminuria.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-11-09A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a Combination of One of the Doses of Each Medication
-
CLINICAL_TRIALS study record update · 2009-11-06A 6-Week, Prospective, Randomized, Double-Blind, Double-Dummy Phase IV Clinical Trial Designed to Evaluate the Efficacy of an Aggressive Multi-Risk Factor Management Strategy With Caduet (A3841045) Versus a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensive Subjects With Additional Risk Factors.
-
CLINICAL_TRIALS study record update · 2009-11-05Outcome After Pediatric Renal Transplantation: Cardiorespiratory Fitness, Cardiovascular Risk Factors and Quality of Life
-
CLINICAL_TRIALS study record update · 2009-11-03A Multi-center, Prospective, Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2009-10-29Epidemiological Study of European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice
-
CLINICAL_TRIALS study record update · 2009-10-28ClinicalTrials.gov study NCT01003561
-
CLINICAL_TRIALS study record update · 2009-10-27Effects of Acupuncture at ST36 and PC6 on Blood Pressure and Endothelial
-
CLINICAL_TRIALS study record update · 2009-10-22PMS Study of MicardisPlus Tablet
-
CLINICAL_TRIALS study record update · 2009-10-15Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation.
-
CLINICAL_TRIALS study record update · 2009-10-15The Practice of Fluid Management in the Post-anesthetic Care Unit (PACU) in Patients Undergoing Elective Surgery: an Observational Study
-
CLINICAL_TRIALS study record update · 2009-10-09Long-Term Study For Amlodipine 10mg In Patients With Essential Hypertension For Whom Amlodipine 5mg Is Insufficiently Effective
-
CLINICAL_TRIALS study record update · 2009-10-01A Randomized, Open Label, Cross-over Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
-
CLINICAL_TRIALS study record update · 2009-09-23A 16-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Anti-inflammatory Actions of 320 mg Diovan in Patients With Type 2 Diabetes With and Without Coronary Artery Disease
-
CLINICAL_TRIALS study record update · 2009-09-23A Prospective, Open-label Study to Assess the Efficacy and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Subjects With Stage 1 and Stage 2 Hypertension
-
CLINICAL_TRIALS study record update · 2009-09-21Feasibility Study of Integrating IC Technology With the WatchWT Comprehensive Weight Reduction Program.
-
CLINICAL_TRIALS study record update · 2009-09-15A Study of Irbesartan 150mg Verses 300mg in Chinese Hypertensive Patients With Diabetes and Microalbuminuria
-
CLINICAL_TRIALS study record update · 2009-09-15Multi-center Open Label, Non-comparative Observational Study of Irbesartan-Hydrochlorothiazide in the Treatment of Hypertension in Chinese Population
-
CLINICAL_TRIALS study record update · 2009-09-15Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients
-
CLINICAL_TRIALS study record update · 2009-09-15A Dose-ranging Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less That 6 Years of Age: A 4-week, Multicenter, Randomized, Double-blind Study With a 1-year, Open-label, Follow-up Period.
-
CLINICAL_TRIALS study record update · 2009-09-15A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension